Bacil Pharma Peer Comparison

BSE: 524516

₹20.34

₹-1.07 (-5.00%)

As on 19-Oct-2026IST

Market cap

₹29 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

46

P/B Ratio

1.1

Div. Yield

0 %

Edit

	Bacil Pharma	Solara Active	Bajaj Healthcare	Hemo Organic
Market cap (₹ Cr)	29	3,125	1,143	16
Revenue (₹ Cr)	--	1,535	656	2
Net Profit (₹ Cr)	0.64	36.94	20.61	-0.73
Net Margin (%)	177.37	2.39	3.77	-30.96
RoE (%)	2.54	3.52	11.28	-43.14
Price to Earnings	45.97	84.58	45.78	--
Price-To-Book	1.14	2.18	2.05	6.57

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Bacil Pharma	Solara Active	Bajaj Healthcare	Hemo Organic
Operating Revenue	0.00	1,535.23	655.82	2.36
Total Income	0.36	1,543.15	662.12	2.36
Total Expenditure	0.18	1,301.42	542.50	2.77
EBITDA	-0.18	233.81	113.32	-0.41
Depreciation	0.00	104.96	29.49	0.00
EBIT	-0.18	128.85	83.83	-0.41
Interest	0.00	89.44	23.52	0.00
Other Income	0.36	7.92	6.31	0.00
Exceptional Items	0.00	-10.39	-33.25	0.00
Profit before Tax	0.18	36.94	33.37	-0.41
Provision for Tax	-0.46	0.00	8.41	0.32
Profit after Tax	0.64	36.94	24.96	-0.73

Liabilities (₹ Cr)

	Bacil Pharma	Solara Active	Bajaj Healthcare	Hemo Organic
Shareholder's Funds	25.27	1,436.09	557.16	3.25
Minority Interest	0.00	0.00	0.00	0.00
Non-Current Liabilities	0.00	249.58	99.59	1.29
Current Liabilities	0.07	765.79	324.40	0.22
Total Liabilities	25.60	2,231.84	833.05	4.98

Assets (₹ Cr)

	Bacil Pharma	Solara Active	Bajaj Healthcare	Hemo Organic
Non-Current Assets	23.89	1,355.21	249.46	0.00
Current Assets	1.45	1,008.80	572.28	4.76
Total Assets	25.60	2,231.84	833.05	4.98
Total Debt*	0.16	776.06	222.62	1.48
Net Current Assets	1.38	243.01	247.88	4.54
Contingent Liabilities	--	60.06	34.51	--

Cashflow (₹ Cr)

	Bacil Pharma	Solara Active	Bajaj Healthcare	Hemo Organic
Cash From Operating Activities	0.40	212.82	21.62	-0.36
Cash Flow from Investing Activities	0.34	-36.83	-14.82	--
Cash from Financing Activities	2.08	-180.48	-6.38	0.24
Net Cash Inflow / Outflow	2.82	-4.49	0.43	-0.12

Ratios

Profitability Ratios

	Bacil Pharma	Solara Active	Bajaj Healthcare	Hemo Organic
ROCE (%)	3.03	6.07	11.40	2.51
ROE (%)	2.54	3.52	11.28	-43.14
ROA (%)	2.45	1.56	2.74	-14.45
EBIT Margin (%)	--	8.39	12.78	-17.53
Net Margin (%)	177.37	2.39	3.77	-30.96
Cash Profit Margin (%)	--	0.00	0.00	6.79

Growth Ratios

	Bacil Pharma	Solara Active	Bajaj Healthcare	Hemo Organic
Revenue Growth (%)	--	27.30	14.25	-2.48
EBIT Growth (%)	60.78	31.63	45.14	-358.89
Net Profit Growth (%)	-38.05	476.29	-51.23	-512.43
EPS Growth (%)	-74.38	566.34	14.62	-513.82
Book Value Growth (%)	4,204.55	17.02	61.16	51.97

Valuation Ratios

	Bacil Pharma	Solara Active	Bajaj Healthcare	Hemo Organic
Price / Earnings	45.99	72.85	18.27	-10.87
Price / Book Value	1.14	2.18	2.05	6.57
Dividend Yield (%)	0.00	0.00	0.44	0.00
EV/EBITDA	-145.61	15.98	11.81	-44.80
Market Cap (₹ Cr)	--	2,063.64	2,121.47	3.11

Solvency Ratios

	Bacil Pharma	Solara Active	Bajaj Healthcare	Hemo Organic
Debt to Equity	0.00	0.12	0.13	0.40
Short term debt to equity ratio	0.01	0.52	0.29	--
Current Ratio	20.71	1.32	1.76	22.12
Quick Ratio	20.71	0.84	1.03	19.76
Interest Coverage	--	1.41	2.42	10.85

Operating Efficiency Ratios

	Bacil Pharma	Solara Active	Bajaj Healthcare	Hemo Organic
Debtors to sales (%)	--	32.97	38.37	100.08
Asset Turnover	0.00	0.65	0.72	0.47
Receivable days	--	89.55	145.27	196.55
Inventory Days	--	89.89	102.90	214.12
Payable days	--	163.33	120.59	310.20
Cash Conversion Cycle	--	16.11	127.58	100.48

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.